PublishedOctober 13, 2020 Category Partner News Ionis' inhaled antisense medicine demonstrates potential as a novel treatment for cystic fibrosis
PublishedSeptember 7, 2020 Category Publications Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.
PublishedAugust 20, 2020 Category Publications Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer.
PublishedJuly 24, 2020 Category Partner News Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Non-CF Patients with Limited Treatment Options
PublishedJuly 7, 2020 Category Partner News New NTM Treatment Guidelines Recommend Insmed's ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of Patients with Refractory MAC Lung Disease